Parametric Portfolio Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.41M Sell
277,250
-90,482
-25% -$1.76M ﹤0.01% 1797
2021
Q4
$6M Buy
367,732
+98,664
+37% +$1.61M ﹤0.01% 1732
2021
Q3
$7.5M Buy
269,068
+667
+0.2% +$18.6K ﹤0.01% 1547
2021
Q2
$7.96M Buy
268,401
+7,748
+3% +$230K ﹤0.01% 1548
2021
Q1
$7.29M Buy
260,653
+959
+0.4% +$26.8K ﹤0.01% 1903
2020
Q4
$7.36M Sell
259,694
-36,497
-12% -$1.03M ﹤0.01% 1813
2020
Q3
$7.45M Buy
296,191
+42,801
+17% +$1.08M 0.01% 1593
2020
Q2
$6.19M Sell
253,390
-16,189
-6% -$395K ﹤0.01% 1729
2020
Q1
$3.99M Sell
269,579
-67,150
-20% -$994K ﹤0.01% 1903
2019
Q4
$5.47M Buy
336,729
+81,921
+32% +$1.33M ﹤0.01% 2005
2019
Q3
$3.31M Buy
254,808
+143,593
+129% +$1.87M ﹤0.01% 2321
2019
Q2
$1.44M Buy
111,215
+53,810
+94% +$698K ﹤0.01% 2855
2019
Q1
$905K Buy
57,405
+4,787
+9% +$75.5K ﹤0.01% 3080
2018
Q4
$1.06M Buy
52,618
+5,784
+12% +$116K ﹤0.01% 2948
2018
Q3
$1.16M Buy
46,834
+9,429
+25% +$234K ﹤0.01% 3009
2018
Q2
$1.03M Sell
37,405
-35,444
-49% -$973K ﹤0.01% 3040
2018
Q1
$2.24M Sell
72,849
-6
-0% -$185 ﹤0.01% 2539
2017
Q4
$2.61M Buy
72,855
+37,808
+108% +$1.35M ﹤0.01% 2423
2017
Q3
$966K Buy
35,047
+5,935
+20% +$164K ﹤0.01% 3067
2017
Q2
$769K Buy
29,112
+1,711
+6% +$45.2K ﹤0.01% 3125
2017
Q1
$570K Buy
27,401
+1,524
+6% +$31.7K ﹤0.01% 3135
2016
Q4
$536K Buy
25,877
+5,040
+24% +$104K ﹤0.01% 3151
2016
Q3
$338K Sell
20,837
-231
-1% -$3.75K ﹤0.01% 3363
2016
Q2
$287K Sell
21,068
-1,856
-8% -$25.3K ﹤0.01% 3466
2016
Q1
$400K Buy
+22,924
New +$400K ﹤0.01% 3446